ZUMWALT LEANNE M 4
4 · Akebia Therapeutics, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
ZUMWALT LEANNE M
Director
Transactions
- Award
Common Stock
2022-06-08+13,700→ 13,700 total - Award
Stock Option (Right to buy)
2022-06-08+20,100→ 20,100 totalExercise: $0.45From: 2023-06-08Exp: 2032-06-08→ Common Stock (20,100 underlying)
Footnotes (2)
- [F1]The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.
- [F2]The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.